Bond J A, Birnbaum L S, Dahl A R, Medinsky M A, Sabourin P J, Henderson R F
Inhalation Toxicology Research Institute, Lovelace Biomedical and Environmental Research Institute, Albuquerque, New Mexico 87185.
Toxicol Appl Pharmacol. 1988 Sep 30;95(3):444-55. doi: 10.1016/0041-008x(88)90362-6.
Propylene chlorohydrins, of which 1-chloro-2-propanol (1-CP) is a constituent, used as intermediates in the manufacture of propylene oxide and have been identified as potential air pollutants. The objective of these studies was to determine whether changes in the inhaled exposure concentration would affect the disposition of 1-CP in rats. In addition, experiments were conducted to identify the carbon atom of 1-CP that is metabolized to CO2. Rats were exposed nose-only to [14C]1-CP for 6 hr to 8.3 +/- 1.0 ppm (26.1 +/- 3.2 micrograms/liter air) or 77 +/- 4 ppm (245 +/- 13 micrograms/liter air) (mean +/- SE). There were two major routes of elimination of 14C, urinary and exhalation of CO2, which together accounted for about 80% of the total 14C in excreta and carcass. Half-times for elimination of 14C in urine as 14CO2 were between 3 and 7 hr with no effect of exposure concentration on the elimination half-times for either route. After the end of exposure, kidneys, livers, trachea, and nasal turbinates contained high concentrations of [14C]1-CP equivalents at both exposure concentrations (30-50 nmol 14C/g tissue for the 8 ppm exposure level and 200-350 nmol 14C/g tissue for the 80 ppm exposure level). Elimination of 14C from tissues was biphasic with about 50% of the material in a tissue being rapidly eliminated with a half-time of 1 to 3 hr and the remaining material slowly eliminated with a half-time of 40 to 80 hr. There was no effect of exposure concentration on elimination half-times in tissues. Major metabolites detected in urine and tissues (liver, kidney, and lung) were N-acetyl-S-(hydroxypropyl)cysteine and/or S-(2-hydroxypropyl)-cysteine. Little unmetabolized 1-CP (less than 1%) was detected in analyzed tissues or urine. We propose a metabolic scheme in which the major pathway for metabolism of 1-CP is to CO2 (which is exhaled) and to cysteine conjugates and mercapturic acids that are excreted in the urine. Both carbon-2 and carbon-3 are metabolized in part to CO2.
氯丙醇(其中1-氯-2-丙醇是其成分之一)用作环氧丙烷生产的中间体,并且已被确定为潜在的空气污染物。这些研究的目的是确定吸入暴露浓度的变化是否会影响大鼠体内1-氯-2-丙醇(1-CP)的代谢。此外,还进行了实验以确定1-CP中代谢为二氧化碳的碳原子。大鼠仅通过鼻腔暴露于[14C]1-CP 6小时,暴露浓度为8.3±1.0 ppm(26.1±3.2微克/升空气)或77±4 ppm(245±13微克/升空气)(平均值±标准误)。14C的消除有两条主要途径,即通过尿液排泄和呼出二氧化碳,这两者合起来约占排泄物和尸体中总14C的80%。以14CO2形式经尿液消除14C的半衰期在3至7小时之间,暴露浓度对任何一条途径的消除半衰期均无影响。暴露结束后,在两种暴露浓度下,肾脏、肝脏、气管和鼻甲中均含有高浓度的[14C]1-CP等效物(8 ppm暴露水平下为30 - 50 nmol 14C/克组织,80 ppm暴露水平下为200 - 350 nmol 14C/克组织)。组织中14C的消除呈双相性,组织中约50%的物质以1至3小时的半衰期快速消除,其余物质以40至80小时的半衰期缓慢消除。暴露浓度对组织中的消除半衰期没有影响。在尿液和组织(肝脏、肾脏和肺)中检测到的主要代谢产物是N-乙酰-S-(羟丙基)半胱氨酸和/或S-(2-羟丙基)半胱氨酸。在分析的组织或尿液中检测到的未代谢1-CP很少(不到1%)。我们提出了一种代谢方案,其中1-CP的主要代谢途径是生成二氧化碳(呼出)以及生成半胱氨酸共轭物和硫醚氨酸,并通过尿液排泄。碳-2和碳-3都有一部分代谢为二氧化碳。